{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T23:09:32Z","timestamp":1778454572979,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer US","isbn-type":[{"value":"9781071650363","type":"print"},{"value":"9781071650370","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5037-0_8","type":"book-chapter","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:34:43Z","timestamp":1778452483000},"page":"119-131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Laboratory-Scale Production of Recombinant IgG Antibodies"],"prefix":"10.1007","author":[{"given":"Takahiro","family":"Anzai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","author":"G Kohler","year":"1975","unstructured":"Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495\u2013497","journal-title":"Nature"},{"issue":"3","key":"8_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4161\/mabs.2.3.11641","volume":"2","author":"FA Harding","year":"2010","unstructured":"Harding FA, Stickler MM, Razo J, DuBridge RB (2010) The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions. Mabs 2(3):256\u2013265","journal-title":"Mabs"},{"issue":"8","key":"8_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0167-5699(96)10025-6","volume":"17","author":"M Br\u00fcggemann","year":"1996","unstructured":"Br\u00fcggemann M, Neuberger MS (1996) Strategies for expressing human antibody repertoires in transgenic mice. Immunol Today 17(8):391\u2013397","journal-title":"Immunol Today"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nbt.2825","volume":"32","author":"EC Lee","year":"2014","unstructured":"Lee EC, Liang Q, Ali H, Bayliss L, Beasley\u00a0A, Bloomfield-Gerdes T, Bonoli L, Brown R, Campbell J, Carpenter A, Chalk S, Davis A, England N, Fane-Dremucheva A, Franz B, Germaschewski V, Holmes H, Holmes S, Kirby\u00a0I, Kosmac M, Legent A, Lui H, Manin\u00a0A, O\u2019Leary S, Paterson J, Sciarrillo R, Speak A, Spensberger D, Tuffery L, Waddell\u00a0N, Wang\u00a0W, Wells S, Wong V, Wood A, Owen\u00a0MJ, Friedrich\u00a0GA, Bradley A (2014) Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery. Nat Biotechnol 32:356\u2013363","journal-title":"Nat Biotechnol"},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/332323a0","volume":"332","author":"L Riechmann","year":"1988","unstructured":"Riechmann L, Clark M, Waldmann H, Winter G (1988) Reshaping human antibodies for therapy. Nature 332:323\u2013327","journal-title":"Nature"},{"key":"8_CR6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/321522a0","volume":"321","author":"PT Jones","year":"1986","unstructured":"Jones PT, Dear PH, Foote J, Neuberger MS, Winter G (1986) Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321:522\u2013525","journal-title":"Nature"},{"key":"8_CR7","unstructured":"BCC Research (2024). Antibody Drugs: Technologies and Global Markets, Research and Markets. [https:\/\/www.researchandmarkets.com\/reports\/5464887\/]"},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrd.2016.268","volume":"16","author":"A Beck","year":"2017","unstructured":"Beck A, Goetsch L, Dumontet C, Corva\u00efa N (2017) Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov 16:315\u2013337","journal-title":"Nat Rev Drug Discov"},{"issue":"2 Pt A","key":"8_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molimm.2015.01.003","volume":"67","author":"C Spiess","year":"2015","unstructured":"Spiess C, Zhai Q, Carter PJ, Zha J (2015) Alternative molecular formats and therapeutic applications for bispecific antibodies. Mol Immunol 67(2 Pt A):95\u2013106","journal-title":"Mol Immunol"},{"issue":"5","key":"8_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4161\/mabs.1.5.9676","volume":"1","author":"K Chapman","year":"2009","unstructured":"Chapman K, Pullen N, Coney L, Dempster M, Andrews L, Bajramovic J, Baldrick P, Buckley L, Jacobs A, Hale G, Green C, Ragan I, Robinson V (2009) Preclinical development of monoclonal antibodies: considerations for the use of non-human primates. Mabs 1(5):505\u2013516","journal-title":"Mabs"},{"issue":"1","key":"8_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nprot.2017.126","volume":"13","author":"R Vazquez-Lombardi","year":"2018","unstructured":"Vazquez-Lombardi R, Nevoltris D, Luthra A, Schofield P, Zimmermann C, Christ D (2018) Transient expression of human antibodies in mammalian cells. Nat Protoc 13(1):99\u2013117","journal-title":"Nat Protoc"},{"key":"8_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pep.2017.03.018","volume":"134","author":"NK Jain","year":"2017","unstructured":"Jain NK, Barkowski-Clark S, Altman R, Johnson K, Sun F, Zmuda J, Liu CY, Kita A, Schulz R, Neill A, Ballinger R, Patel R, Liu J, Mpanda A, Huta B, Chiou H, Voegtli W, Panavas T (2017) A high density CHO-S transient transfection system: Comparison of ExpiCHO and Expi293. Protein Expr Purif 134:40\u201346","journal-title":"Protein Expr Purif"},{"issue":"2","key":"8_CR13","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/cas.13907","volume":"110","author":"M Yasunaga","year":"2019","unstructured":"Yasunaga M, Saijou S, Hanaoka S, Anzai T, Tsumura R, Matsumura Y (2019) Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer-specific molecule. Cancer Sci 110(2):761\u2013770","journal-title":"Cancer Sci"},{"issue":"1","key":"8_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3892\/or.2020.7850","volume":"45","author":"R Tsumura","year":"2021","unstructured":"Tsumura R, Anzai T, Manabe S, Takashima H, Koga Y, Yasunaga M, Matsumura Y (2021) Antitumor effect of humanized anti-tissue factor antibody-drug conjugate in a model of peritoneal disseminated pancreatic cancer. Oncol Rep 45(1):329\u2013336","journal-title":"Oncol Rep"},{"issue":"7","key":"8_CR15","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/ph15070837","volume":"15","author":"T Anzai","year":"2022","unstructured":"Anzai T, Saijou S, Takashima H, Hara M, Hanaoka S, Matsumura Y, Yasunaga M (2022) Identification of CD73 as the antigen of an antigen unknown monoclonal antibody established by exosome immunization, and its antibody-drug conjugate exerts an antitumor effect on glioblastoma cell lines. Pharmaceuticals 15(7):837","journal-title":"Pharmaceuticals"},{"issue":"4","key":"8_CR16","first-page":"1234","volume":"115","author":"R Tsumura","year":"2024","unstructured":"Tsumura R, Anzai T, Koga Y, Takashima H, Matsumura Y, Yasunaga M (2024) Anti-tissue factor antibody conjugated with monomethylauristatin E or deruxtecan in pancreatic cancer models. Cancer Sci 115(4):1234\u20131244","journal-title":"Cancer Sci"},{"issue":"2","key":"8_CR17","doi-asserted-by":"publisher","first-page":"e0116878","DOI":"10.1371\/journal.pone.0116878","volume":"10","author":"R Haryadi","year":"2015","unstructured":"Haryadi R, Ho S, Kok YJ, Pu HX, Zheng L, Pereira NA, Li B, Bi X, Goh LT, Yang Y, Song Z (2015) Optimization of Heavy Chain and Light Chain Signal Peptides for High Level Expression of Therapeutic Antibodies in CHO Cells. PLoS One 10(2):e0116878","journal-title":"PLoS One"}],"container-title":["Methods in Molecular Biology","Bispecific Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5037-0_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:34:44Z","timestamp":1778452484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5037-0_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650363","9781071650370"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5037-0_8","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}